Viewing Study NCT01185028

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-02-02 @ 11:05 AM
Study NCT ID: NCT01185028
Status: COMPLETED
Last Update Posted: 2021-10-05
First Post: 2010-08-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures
Sponsor: National Institutes of Health Clinical Center (CC)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis C Infection View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic HCV View
None HCV Treatment Nonresponders View
None HCV Treatment Relapsers View
None HIV-HCV Co-Infection View
None Nitazoxanide View
None Hepatitis C View